NASDAQ: RXDX - Prometheus Biosciences, Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Prometheus Biosciences, Inc.

200.00200.00150.00150.00100.00100.0050.0050.000.000.00Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 57.09 -100% -11.01 -100%
P/S 648.54 33.5 1836.15%
P/BV 6.53 4.61 41.58%
P/FCF -75.87 39.66 -291.31%
Ev/Ebitda -28.49 -19.46 46.43%
Ev/S 610.29 22.56 2605.32%
Ev/FCF -32.94 45.47 -172.44%
E/P -0.0143 0.0172 -182.91%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-2144.12 -14.42 14768.35% -2131.92 +0.572%
ROE -30.09 9.01 -433.99%
ROA -27.19 0.0151 -179609.92%
ROIC -40.86 7.63 -635.21%
ROS -2016.18 -26.5 7506.87%
ROCE -20.98 13.75 -252.55%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.2023 -3.73 -94.57% -0.2986 -32.24%
Nеt Debt/Ebitda 1.8 -3.19 -156.47%
Debt/Ratio 0.0398 0.1777 -77.59%
Debt/Equity 0.0417 1.57 -97.35%
Debt/Net Income -0.2152 0.8429 -125.53%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5467 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2387 -100%
Average dividend growth 0 1.55 -100%
Average percentage for 5 years 0 0.4967 -100%
Average percentage for payments 0 43.73 -100%
Difference from average difference in sector -0.5467

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
299.5 73.67 306.54%
Growth impulse Ebitda in 5 years 908.7 15.28 5846.99%
Growth impulse Net Income in 5 years 362.93 -33.08 -1197.13%
Growth impulse FCF in 5 years 578.44 -6.99 -8375.25%
Growth impulse EPS in 5 years 166.01 -59.11 -380.85%
IP Score
4.11/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription